查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528048

电疗/生物电医学全球市场

Electroceuticals / Bioelectric Medicine
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

电疗/生物电医学全球市场预计2030年将达284亿美元

电疗/生物电医学的全球市场预计 2023 年为 185 亿美元，预计到 2030 年将达到 284 亿美元，2023-2030 年分析期间复合年增长率为 6.3%。心臟心律调节器和 ICD 是本报告分析的细分市场之一，预计复合年增长率为 7.1%，到分析期结束时将达到 179 亿美元。分析期间，人工电子耳领域的复合年增长率预计为 5.3%。

美国市场预估成长77亿美元，中国复合年增率为7.2%

预计2023年美国电疗/生物电医学市场规模将达77亿美元。中国作为世界第二大经济体，预计2030年市场规模将达23亿美元，2023-2030年分析期间复合年增长率为7.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.6% 和 6.1%。在欧洲，德国的复合年增长率预计约为 6.1%。

全球电子医学/生物电子医学市场 - 主要趋势和驱动因素总结

什么是电疗法以及它们将如何改变医疗保健？

电製药，又称生物电製药，是医学的前沿领域，专注于利用电脉衝调节人体神经系统并治疗各种疾病。与使用化学物质触发生物反应的传统药物不同，电治疗药物使用有针对性的电刺激来调节神经活动、影响器官功能并产生治疗效果。这种方法可用于治疗对常规药物有抗药性的疾病和病症，例如某些慢性疼痛症候群、心臟衰竭，甚至精神疾病。电疗的原理在于连接大脑和各种器官的复杂神经网路。透过精确调整这些神经讯号，医生的目标是直接纠正生物电源的异常。

技术如何推进电疗应用？

微电子和生物技术的进步对于推进电疗领域至关重要。神经映射方面的新进展以及能够向体内目标区域发送精确电脉衝的小型植入式设备的开发极大地扩展了该技术的潜在应用。这些设备通常连接到穿戴式装置或外部控制器，以便根据患者的特定需求即时客製化治疗方案。这种高精度不仅提高了治疗效果，还最大限度地减少了药物等全身性治疗常见的副作用。此外，正在进行的生物电讯号和神经介面研究预计将开发出更复杂的疾病治疗方法，彻底改变慢性病的管理并减少对药物干预的依赖。

电子药物在目前治疗中发挥什么作用？

电子製药目前应用于各种医疗环境，特别是疼痛、神经病变和心臟病的治疗。例如，脊髓刺激设备可以显着减轻药物治疗不足或不适当的患者的慢性疼痛。同样，深层脑部刺激器在治疗帕金森氏症症状方面显示出希望，可显着改善患者的生活品质。在心臟病学中，心律调节器和植入式心臟整流去颤器(ICD) 可纠正异常心律并预防心臟衰竭和心臟猝死。电子药物在治疗多种疾病方面的多功能性提高了电子药物将成为未来医疗实践中的支柱的可能性，特别是随着技术的进步和神经系统中新的​​治疗标靶的发现。

是什么推动了电疗药物市场的成长？

电疗药物市场的成长受到技术创新、全球人口老化和慢性病负担增加等多种因素的推动。随着生物医学研究提供更复杂和小型化的设备，电子製药的应用范围将会扩大，使临床医生能够以更大的功效解决更广泛的病症。世界人口老化的变化正在增加适合电疗的慢性疾病的盛行率，例如心血管疾病和神经系统疾病。此外，不断上涨的医疗费用，特别是长期使用药物，通常使电疗药物成为经济有效的替代方案。消费者的行为也在改变，人们越来越倾向于副作用较少的无药物治疗。

受访企业范例（共50家）

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP11726

Global Electroceuticals / Bioelectric Medicine Market to Reach US$28.4 Billion by 2030

The global market for Electroceuticals / Bioelectric Medicine estimated at US$18.5 Billion in the year 2023, is expected to reach US$28.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$17.9 Billion by the end of the analysis period. Growth in the Cochlear Implants segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.7 Billion While China is Forecast to Grow at 7.2% CAGR

The Electroceuticals / Bioelectric Medicine market in the U.S. is estimated at US$7.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Electroceuticals/Bioelectric Medicine Market - Key Trends & Drivers Summarized

What Are Electroceuticals and How Are They Transforming Medicine?

Electroceuticals, also known as bioelectric medicines, represent a cutting-edge field in medical science that focuses on using electrical impulses to modulate the body's nervous system to treat a variety of ailments. Unlike traditional pharmaceuticals that use chemicals to provoke a biological response, electroceuticals employ targeted electrical stimulation to modulate nerve activity, influencing organ function and offering therapeutic benefits. This approach can be used to treat diseases and conditions that have been resistant to conventional medicines, such as certain chronic pain syndromes, heart failure, and even mental health disorders. The principle behind electroceuticals lies in the intricate network of nerves that link the brain to different organs; by precisely adjusting these nerve signals, doctors aim to correct abnormalities directly at their bioelectrical source.

How Is Technology Advancing Electroceutical Applications?

The advancements in microelectronics and biotechnology have been pivotal in propelling the field of electroceuticals forward. Modern techniques in neural mapping and the development of miniature, implantable devices capable of delivering precise electrical impulses to targeted areas within the body have significantly broadened the potential applications of this technology. These devices are often connected to wearable or external controllers that allow for real-time adjustments in therapy, tailored to patient-specific needs. This level of precision not only enhances the effectiveness of treatment but also minimizes side effects commonly associated with more systemic treatments like drugs. Additionally, ongoing research in bioelectrical signaling and neural interfaces promises to unlock even more sophisticated methods of treating diseases, potentially revolutionizing the management of chronic conditions and reducing dependence on pharmacological interventions.

What Role Does Electroceuticals Play in Current Medical Treatments?

Currently, electroceuticals are being applied in a variety of medical contexts, most notably in the management of pain, neurological disorders, and cardiac issues. For example, spinal cord stimulators can significantly alleviate chronic pain in patients for whom pharmaceutical treatments are insufficient or inappropriate. Similarly, deep brain stimulators have shown promise in treating Parkinson’s disease symptoms, substantially improving life quality for affected individuals. In cardiology, devices like pacemakers and implantable cardioverter-defibrillators (ICDs) correct abnormal heart rhythms, crucially preventing heart failure and sudden cardiac death. The versatility of electroceuticals in treating such diverse conditions underscores their potential to be a mainstay in future medical practices, particularly as technologies improve and new therapeutic targets within the nervous system are discovered.

What Drives the Growth in the Electroceuticals Market?

The growth in the electroceuticals market is driven by several factors, including technological innovations, an aging global population, and an increasing burden of chronic diseases. As biomedical research delivers more sophisticated and miniaturized devices, the applicability of electroceuticals expands, allowing clinicians to address a broader range of conditions with greater efficacy. The demographic shift towards an older population worldwide leads to a higher prevalence of chronic diseases, such as cardiovascular disorders and neurological conditions, which are well-suited for electroceutical interventions. Furthermore, the rising cost of healthcare, particularly the long-term use of pharmaceuticals, makes electroceuticals a cost-effective alternative in many cases. Consumer behavior is also shifting; there is a growing preference for treatments that have fewer side effects and do not involve drug intake, which often aligns well with electroceutical solutions.

Select Competitors (Total 50 Featured) -

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Electroceuticals / Bioelectric Medicine - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • An Introduction to Electroceuticals/Bioelectric Medicine
    • Using Electrical Stimulation in Nerves: Historical Perspective
    • Types of Electroceutical Devices
    • Major Applications of Electroceuticals/Bioelectric Medicine
    • Global Market Prospects & Outlook
    • Implantable Electroceutical Devices: The Leading Category
    • Cardiac Pacemakers & Implantable Cardioverter Defibrillators Segment Lead the Global Market
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Competition
    • Global DBS Market Share Breakdown of Revenues by Leading Players: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Electroceutical/Biomedical Medicine Emerges to Overcome Drawbacks of Traditional Treatments
    • Faster Healing: A Key Benefit Fueling Growth in Electroceuticals Market
    • Ineffectiveness of Drug Therapy and Issues with Side Effects Present Opportunities for Electroceuticals Market
    • Disease-specific Electroceuticals to Drive Future Gains
    • Aging Global Population Raises Risk of Neurological & Cardiovascular Diseases, Fueling Market Outlook
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Prevalence of Cardiovascular Diseases and Need for Effective Treatments Supports Market Growth
    • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Cardiac Pacemaker: A Solution for Cardiac Arrythmias
    • Transcatheter Cardiac Pacemakers: Benefits Fuel Market Growth
    • Technological Advancements to Transform Cardiac Pacemaker Devices Marketplace
    • Rising Incidence of Neurological Disorders and Need for Novel Therapies to Spur Market Growth
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Bioelectronic Medicine Emerges as a Vital Therapy for Targeted Neuromodulation
    • Deep Brain Stimulators: Useful in Treatment of Neurodegenerative Diseases
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease in Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Developments in Vagal Nerve Stimulation (VNS) Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Biodegradable Devices For Nerve Recovery
    • Bioelectric Medicine: A Potential Treatment Approach for Crohn's Disease
    • Growing Prevalence of Hearing Loss Boosts Opportunities in the Cochlear Implants Market
    • Global Prevalence (%) by Severity of Hearing Loss
    • Vendors Focus on Innovations in Cochlear Implants
    • Developing Economies to Boost Long-term Prospects
    • Electroceutical Acupuncture: Emerging Pain Therapy
    • Neuropuncture - The Electroceutical Technology to Treat Pain & Injury
    • Bioelectronics Technology Fuels Advances in Next-Generation of Device Therapeutics
    • Market Benefits from the Significant Advantages of Bioelectronics
    • Overcoming the Challenges
    • Increasing Research Activity in Bioelectric Medicine Drives Market Opportunities
    • Market Poised to Benefit from the Development of New Bioelectronic Devices
    • Technological Advancements to Boost Growth Prospects
    • Rise in Healthcare Expenditure to Drive Growth
    • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiac Pacemakers & ICDs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cochlear Implants by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Clinics & ASCs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Electroceuticals / Bioelectric Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION